The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.
复制标题
DOI:
10.1084/jem.20011956
复制
发表时间:
2002-05-06
期刊:
影响因子:
--
通讯作者:
Blumberg RS
中科院分区:
文献类型:
--
作者:
Neurath MF;Weigmann B;Finotto S;Glickman J;Nieuwenhuis E;Iijima H;Mizoguchi A;Mizoguchi E;Mudter J;Galle PR;Bhan A;Autschbach F;Sullivan BM;Szabo SJ;Glimcher LH;Blumberg RS
The balance between pro and antiinflammatory cytokines secreted by T cells regulates both the initiation and perpetuation of inflammatory bowel diseases (IBD). In particular, the balance between interferon (IFN)-γ/interleukin (IL)-4 and transforming growth factor (TGF)-β activity controls chronic intestinal inflammation. However, the molecular pathways that evoke these responses are not well understood. Here, we describe a critical role for the transcription factor T-bet in controlling the mucosal cytokine balance and clinical disease. We studied the expression and function of T-bet in patients with IBD and in mucosal T cells in various T helper (Th)1- and Th2-mediated animal models of chronic intestinal inflammation by taking advantage of mice that lack T-bet and retroviral transduction techniques, respectively. Whereas retroviral transduction of T-bet in CD62L+ CD4+ T cells exacerbated colitis in reconstituted SCID mice, T-bet–deficient T cells failed to induce colitis in adoptive transfer experiments suggesting that overexpression of T-bet is essential and sufficient to promote Th1-mediated colitis in vivo. Furthermore, T-bet–deficient CD62L− CD4+ T cells showed enhanced protective functions in Th1-mediated colitis and exhibited increased TGF-β signaling suggesting that a T-bet driven pathway of T cell activation controls the intestinal balance between IFN-γ/IL-4 and TGF-β responses and the development of chronic intestinal inflammation in T cell–mediated colitis. Furthermore, TGF-β was found to suppress T-bet expression suggesting a reciprocal relationship between TGF-β and T-bet in mucosal T cells. In summary, our data suggest a key regulatory role of T-bet in the pathogenesis of T cell–mediated colitis. Specific targeting of this pathway may be a promising novel approach for the treatment of patients with Crohn's disease and other autoimmune diseases mediated by Th1 T lymphocytes.
登录
查看更多内容
影响因子:
15.3
作者:
Finotto, S;De Sanctis, G T;Lehr, H A;Herz, U;Buerke, M;Schipp, M;Bartsch, B;Atreya, R;Schmitt, E;Galle, P R;Renz, H;Neurath, M F
通讯作者:
Neurath, M F
影响因子:
15.3
作者:
Carter, L L;Murphy, K M
通讯作者:
Murphy, K M
影响因子:
32.4
作者:
Grogan, JL;Mohrs, M;Locksley, RM
通讯作者:
Locksley, RM
影响因子:
32.4
作者:
Kim, JI;Ho, IC;Glimcher, LH
通讯作者:
Glimcher, LH
影响因子:
56.9
作者:
Finotto, S;Neurath, MF;Glimcher, LH
通讯作者:
Glimcher, LH